NovaBay Pharmaceuticals Reports 2015 Fourth Quarter and Full Year Financial Results

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical Company focusing on commercializing its prescription Avenova® Lid and Lash Cleanser for the domestic eye care market, reports financial results for the three and 12 months ended December 31, 2015, and provides a business update. Fourth Quarter 2015 versus Third Quarter 2015 Avenova Highlights 41% increase in sales to a record $1.6 million 29% increase in the number of optometrists and ophtha